{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:37:45Z","timestamp":1790861865213,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Center for Integrated Animal Genomics of Iowa State University"},{"name":"Lysosomal Storage Disease Research Consortium"},{"name":"The Sanfilippo Children's Research Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.ymgme.2012.07.017","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T04:36:05Z","timestamp":1343190965000},"page":"129-135","source":"Crossref","is-referenced-by-count":6,"title":["Accelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice"],"prefix":"10.1016","volume":"107","author":[{"given":"Eman E.A.","family":"Mohammed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Snella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Rutz-Mendicino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin D.","family":"Echevarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafi","family":"Awedikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Matthew","family":"Ellinwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.07.017_bb0205","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","article-title":"Substrate reduction therapy","volume":"97","author":"Platt","year":"2008","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0015","doi-asserted-by":"crossref","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","article-title":"Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase","volume":"96","author":"Li","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1203\/00006450-199807000-00012","article-title":"Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA","volume":"44","author":"Fischer","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0025","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1471-4159.1985.tb05544.x","article-title":"Neurochemical characterization of canine alpha-L-iduronidase deficiency disease","volume":"45","author":"Constantopoulos","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0030","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1471-4159.1980.tb11220.x","article-title":"Mucopolysaccharidosis types IH, IS, II, and IIIA: glycosaminoglycans and lipids of isolated brain cells and other fractions from autopsied tissues","volume":"34","author":"Constantopoulos","year":"1980","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0035","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00005072-199710000-00010","article-title":"Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics","volume":"56","author":"Jones","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/00005072-199802000-00006","article-title":"Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics","volume":"57","author":"Jones","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0045","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/glycob\/9.12.1389","article-title":"A mouse model for mucopolysaccharidosis type III A","volume":"9","author":"Bhaumik","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0050","first-page":"434","article-title":"Hurler's and Sanfilippo's variants of mucopolysaccharidosis. Cerebral pathology and lipid chemistry","volume":"91","author":"Dekaban","year":"1971","journal-title":"Arch. Pathol."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0210","series-title":"American Society of Human Genetics 54th Annual Meeting, Toronto, Ontario, Canada","first-page":"317","article-title":"Canine mucopolysaccharidosis IIIB: aspects of visceral and brain pathology","author":"Ellinwood","year":"2004"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbalip.2004.08.011","article-title":"Consequences of NPC1 and NPC2 loss of function in mammalian neurons","volume":"1685","author":"Walkley","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0065","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1073\/pnas.95.21.12147","article-title":"Complex gangliosides are essential in spermatogenesis of mice: possible roles in the transport of testosterone","volume":"95","author":"Takamiya","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0070","doi-asserted-by":"crossref","first-page":"13744","DOI":"10.1074\/jbc.274.20.13744","article-title":"Attenuation of interleukin 2 signal in the spleen cells of complex ganglioside-lacking mice","volume":"274","author":"Zhao","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0075","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1073\/pnas.93.20.10662","article-title":"Mice with disrupted GM2\/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system","volume":"93","author":"Takamiya","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0080","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.96.13.7532","article-title":"Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects","volume":"96","author":"Sheikh","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0085","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0304-4165(02)00403-8","article-title":"Beta1,4-N-acetylgalactosaminyltransferase\u2013GM2\/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides","volume":"1573","author":"Furukawa","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.2000.7504","article-title":"A functional role for complex gangliosides: motor deficits in GM2\/GD2 synthase knockout mice","volume":"166","author":"Chiavegatto","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0095","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1073\/pnas.0407785102","article-title":"Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon\u2013glial interactions","volume":"102","author":"Yamashita","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0100","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.expneurol.2005.04.017","article-title":"Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice","volume":"195","author":"Pan","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0105","doi-asserted-by":"crossref","first-page":"22405","DOI":"10.1073\/pnas.0912336106","article-title":"Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues","volume":"106","author":"Ohmi","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","article-title":"Secondary accumulation of gangliosides in lysosomal storage disorders","volume":"15","author":"Walkley","year":"2004","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0115","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/cercor\/10.10.1028","article-title":"Gangliosides as modulators of dendritogenesis in normal and storage disease-affected pyramidal neurons","volume":"10","author":"Walkley","year":"2000","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0120","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0306-4522(95)00208-Z","article-title":"Pyramidal neurons with ectopic dendrites in storage diseases exhibit increased GM2 ganglioside immunoreactivity","volume":"68","author":"Walkley","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0125","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1098\/rstb.2003.1276","article-title":"Neurobiology and cellular pathogenesis of glycolipid storage diseases","volume":"358","author":"Walkley","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/geno.1995.1058","article-title":"beta-1,4-N-Acetylgalactosaminyltransferase involved in ganglioside synthesis: cDNA sequence, expression, and chromosome mapping of the mouse gene","volume":"27","author":"Sango","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1172\/JCI5542","article-title":"A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder","volume":"103","author":"Liu","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0140","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/hmg\/9.7.1087","article-title":"Alleviation of neuronal ganglioside storage does not improve the clinical course of the Niemann\u2013Pick C disease mouse","volume":"9","author":"Liu","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0145","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0960-9822(03)00531-1","article-title":"Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent","volume":"13","author":"Gondre-Lewis","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0215","series-title":"Report of the AVMA Panel on Euthanasia, JAVMA","first-page":"669","author":"AVMA","year":"2001"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0220","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2144\/00291bm09","article-title":"Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT)","volume":"29","author":"Truett","year":"2000","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0165","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.1371\/journal.pone.0000772","article-title":"Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B","volume":"2","author":"Heldermon","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0170","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/hmg\/5.6.711","article-title":"Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids","volume":"5","author":"Fujita","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0175","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF02533991","article-title":"Two procedures to remove polar contaminants from a crude brain lipid extract by using prepacked reversed-phase columns","volume":"22","author":"Kyrklund","year":"1987","journal-title":"Lipids"},{"key":"10.1016\/j.ymgme.2012.07.017_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2011.04.040","article-title":"Evaluation of miglustat treatment in patients with type III mucopolysaccharidosis: a randomized, double-blind, placebo-controlled study","author":"Guffon","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0230","first-page":"139","article-title":"Novel pathologic findings associated with urinary retention in a mouse model of mucopolysaccharidosis type IIIB","volume":"59","author":"Gografe","year":"2009","journal-title":"Comp. Med."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0190","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/cne.20355","article-title":"Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders","volume":"480","author":"McGlynn","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0195","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1023\/B:GLYC.0000043294.62504.2c","article-title":"Glycosphingolipids and mitochondria: role in apoptosis and disease","volume":"20","author":"Morales","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgme.2012.07.017_bb0200","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.febslet.2009.10.011","article-title":"Brain gangliosides in axon\u2013myelin stability and axon regeneration","volume":"584","author":"Schnaar","year":"2010","journal-title":"FEBS Lett."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212002739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212002739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T13:09:39Z","timestamp":1561986579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212002739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1096719212002739"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.07.017","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}